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Objective: To assess the autonomic system in patients with polycystic ovary syndrome (PCOS).
Materials and methods: Thirty-seven adult patients with PCOS and 33 healthy controls were enrolled in
the study. The electrophysiological assessments of the autonomic nervous system function were per-
formed using sympathetic skin response and ReR interval variation tests.
Results: The mean latency of sympathetic skin response in PCOS patients was signiﬁcantly delayed
compared with the controls (p ¼ 0.001). The mean amplitude of sympathetic skin response was
signiﬁcantly lower in comparison with the controls (p ¼ 0.01). Mean ReR interval variation during deep
breathing was also signiﬁcantly delayed (p ¼ 0.04).
Conclusion: There are parasympathetic dysfunction and sympathetic dysfunction in patients with PCOS.
This may be easily demonstrated with sympathetic skin response and ReR interval variation tests.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Polycystic ovary syndrome (PCOS) is the most common endo-
crine disorder in women of reproductive age. It occurs in about
6e10% of women [1,2]. Despite decades of research, the complex
pathogenesis of PCOS remains incompletely understood. The
symptoms of PCOS are amenorrhea, oligomenorrhea, hirsutism,
obesity, infertility, anovulation, and acne. The disease can lead to
marital and social maladjustment and can impair sexual func-
tioning [3]. According to the Rotterdam Criteria, PCOS is diagnosed
in the presence of at least two of three criteria: menstrual disorders
or amenorrhoea with chronic lack of ovulation, clinical and/or
biochemical features of hyperandrogenism, and the presence of
polycystic ovaries in ultrasonography after the exclusion of other
endocrine disorders [4].
PCOS is an important metabolic disorder, as women with PCOS
may have signiﬁcant insulin resistance, glucose intolerance,
obesity, hypertension, and dyslipidemia. Adrenergic overactivity
leads to the formation of these factors. Adrenergic overactivity is an
important prognostic factor for the development of cardiovascular
disorders [5e7]. Previous studies indicated that the ANS plays any of Medicine, Department of
bstetrics & Gynecology. Publishedimportant role in the regulation of ovarian physiology [8]. Few re-
ports showed the role of increased sympathetic activity in patients
with PCOS [9,10]. Autonomic dysfunction has also been reported to
be associated with adverse cardiovascular events [11].There is a
relationship between the ANS and cardiovascular mortality [12].
To our knowledge, there are no studies to date evaluating the
relationship between the ANS and PCOS using electromyography
(EMG) in current literature. The present study was conducted to
assess the ANS in patients with PCOS using sympathetic skin
response (SSR) and ReR interval variation (RRIV) tests in EMG.
Materials and methods
Thirty-seven adult patients with PCOS and 33 healthy controls
who were referred to the Kirikkale University Gynecology Clinic,
Kirikkale, Turkey were enrolled in the present study, PCOS was
diagnosed according to the Rotterdam Criteria. Age-matched,
healthy, regularly menstruating, and nulliparous women were
included as controls. Women with menstrual irregularities, hypo-
thyroidism, diabetes, and women on any hormonal therapy or
drugs were excluded. The study was approved by the Kirikkale
University local ethic committee. All research procedures were in
accordance with the ethical standards of the responsible commit-
tee on human experimentation (institutional and national) and
with the Helsinki Declaration of 1975, as revised in 2000. Informed
consent/permission was obtained from all parent participants.by Elsevier Taiwan LLC. All rights reserved.
Table 1
Baseline characteristics of the study population.
Variables Patients (n ¼ 37) Controls (n ¼ 34) p
Mean ± SD Mean ± SD
Year (y) 21.56 ± 3.37 21.20 ± 1.85 0.58
Body mass index (kg/m2) 22.62 ± 3.66 21.02 ± 3.22 0.05
Total cholesterol (mg/dL) 167.97 ± 28.36 163.84 ± 16.83 0.46
HDL cholesterol (mg/dL) 61.27 ± 11.52 58.24 ± 9.21 0.23
LDL cholesterol (mg/dL) 97.86 ± 21.46 94.48 ± 18.92 0.48
Triglyceride (mg/dL) 84.72 ± 39.13 74.06 ± 26.56 0.19
Blood glucose (mg/dL) 92.62 ± 9.16 89.54 ± 6.97 0.12
FSH (IU/L) 5.26 ± 1.63 5.60 ± 1.65 0.40
LH (IU/L) 10.07 ± 5.32 8.57 ± 3.69 0.18
Estradiol (pg/mL) 50.22 ± 7.60 46.94 ± 15.07 0.26
Testesterone (ng/mL) 0.49 ± 0.17 0.41 ± 0.11 0.01
DHEAS (mcg/dL) 282.59 ± 100.89 251 ± 77.90 0.15
Insulin (IU/mL) 11.15 ± 3.95 8.87 ± 3.80 0.02
DHEAS¼ dehydroepiandrosterone; FSH¼ follicle stimulating hormone; HDL¼ high
density lipoprotein; LDL ¼ low density lipoprotein; LH ¼ luteinizing hormone.
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convened by the National Institutes of Health (NIH) in 2012 [13].
There are four phenotypes. Phenotype 1 (classic PCOS) includes
clinical and/or biochemical evidence of hyperandrogenism and
hyperandrogenism, evidence of oligoanovulation, and ultrasono-
graphic evidence of a polycystic ovary. Phenotype 2 (hyper-
androgenic anovulation) includes clinical and/or biochemical
evidence of hyperandrogenism and evidence of oligoanovulation.
Phenotype 3 (ovulatory PCOS) includes clinical and/or biochemical
evidence of hyperandrogenism and hyperandrogenism, and ultra-
sonographic evidence of a polycystic ovary. Phenotype 4 (non-
hyperandrogenic PCOS) includes evidence of oligoanovulation and
ultrasonographic evidence of a polycystic ovary. We classiﬁed our
patients according to these classiﬁcations.
Demographic characteristics including age and body mass index
(BMI) were recorded.
A detailed neurological examinationwas performed, and clinical
autonomic symptoms including feeling faint on orthostatic change
of posture, distal vasomotor dysfunction, sweating abnormalities,
and gastrointestinal, genital, or urinary disorders were recorded in
all participants. Individuals with neurological ﬁndings and auto-
nomic symptoms were not included in the study.
Electrophysiological assessments
The electrophysiological assessments of ANS function were
performed using SSR and RRIV, which were recorded according to
the methods described Shahani et al [14,15]. All participants were
studied in the supine position using the equipment Carefusion
Synergy (CareFusion, USA) by the same physician (MA). All study
sessions were completed in the morning at least 2 hours after a
light breakfast in a quiet semidarkened room with an ambient
temperature of between 23C and 26C ,and an extremity skin
temperature over 31C.
RRIV was used for parasympathetic function and was recorded
using disk electrodes placed on the chest wall across the cardiac
position with a ground electrode on the right axial line at the
lowest rib. Using the triggering mode and adjusting, the sweep
speed two QRS (mainly R waves) of electrocardiography were
simultaneously displayed on the screen. Because the ﬁrst displayed
complex represented the triggering potential, the variation in
timing of the second complex represents the variation in the ReR
interval. Twenty traces were recorded and superimposed, and a
printout was made for subsequent measurement. Five groups of 20
sweepswere recorded at rest and two during forced deep breathing
at six breaths per minute. The band pass was 20e100 Hz, the
sensitivity 0.2 mV, and the sweep duration was 0.2e1 seconds. The
range in the 20 pairs of Re R intervals was termed as (a), and the
mean ReR interval was termed as (b). The RRIV was expressed as a
percentage of the average ReR interval using the formula RRIV¼ a/
b  100 [14,15]. The recordings and calculations were performed
with computer software (SPSS 16, SPSS Inc., Chicago, IL, USA). RRIV
responses at rest and deep breathing were considered abnormal
when they were more than two standard deviations (SD) lower
than mean responses, age-adjusted for a normal population [16].
SSR was used to measure sympathetic function. SSR recordings
were performed using disc electrodes attached to the palm and
dorsum of the right hand. The same device and electrical stimuli
were used, and single square wave pulses of 0.1 seconds duration
and 10e20-mA intensity were applied to the dominant median
nerve at the wrist portion. Latency and amplitude of the response
were analyzed. The latency was measured from the onset of the
stimulus artifact to the onset of the ﬁrst negative deﬂection of the
signal baseline, and the amplitude was measured peak to peak
[14,15].Response latencies were considered pathological when they
were more than two SD above the mean latency of the control
group.
Statistical analysis
All parameters were expressed as mean ± SD, as well as per-
centages (for categorical variables). The patients and healthy con-
trols were compared using a one-way analysis of variance for
continuous parameters and Chi-square test for categorical param-
eters. Bivariate analyses were performed using Pearson correlation.
A p value < 0.05 was considered to be statistically signiﬁcant.
Results
The baseline clinical characteristics of patients with PCOS and
controls are shown in Table 1. Phenotypic presentation of patients
with PCOS are shown in Table 2. No statistically signiﬁcant differ-
ence was found between the patient and the control groups in
terms of age (p ¼ 0.58). There was a slight statistically difference
between both groups in BMI (p ¼ 0.05). Patients with PCOS had
signiﬁcantly higher levels of testosterone and insulin than that of
healthy controls (respectively; p ¼ 0.01, p ¼ 0.02).
Right hand SSR latency was found to be 1.37 ± 0.52 ms in the
patients and 0.86 ± 0.30 ms in the controls; right hand SSR
amplitude was 0.59 ± 0.53 mV in the patients and 1.13 ± 0.65 mV in
the controls. The mean latency of SSR in the patients was signiﬁ-
cantly delayed, compared with the controls (p ¼ 0.001). The mean
amplitude of SSR in the patients was signiﬁcantly lower, compared
with the controls (p ¼ 0.01).
Mean RRIV at rest was detected to be 91.22 ± 54.25% in patients
and 87.06 ± 49.08% in controls. Mean RRIV during deep breathing
was detected to be 112.28 ± 56.50% in the patients and
87.30 ± 42.51% in the controls. No statistically signiﬁcant difference
was found between the patients and the controls in RRIV at rest
(p ¼ 0.73). Mean RRIV during deep breathing was signiﬁcantly
delayed, compared with the controls (p ¼ 0.04). There was no
relationship between RRIV, age, and BMI (Table 3). There was no
relationship between SSR, age, and BMI (Table 4).
Discussion
We investigated autonomic dysfunction in patients with PCOS in
this present study. In this study, both sympathetic systems and
parasympathetic systems were evaluated with SSR and RRIV. SSR
Table 2
Phenotypic presentation of patients with polycystic ovary syndrome (PCOS).
Phenotype Number of cases
Phenotype 1 (classic PCOS) 12
Phenotype 2 (hyperandrogenic anovulation) 9
Phenotype 3 (ovulatory PCOS) 6
Phenotype 4 (nonhyperandrogenic PCOS) 10
Table 4
The correlations between sympathetic skin response, age, and body mass index.
Age p BMI p
rp rp
SSR latency 0.02 0.86 0.05 0.63
SSR amplitude 0.01 0.97 0.18 0.12
BMI ¼ body mass index; SSR ¼ sympathetic skin response.
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which can easily be performed using an electromyography device.
RRIV is a reliable test for showing the parasympathetic nervous
system. SSR is a practical method for evaluating sympathetic small
unmyelinated C-ﬁbers, which cannot be assessed with standard
electrophysiological studies [16,17].
The present study showed dysfunctions in both sympathetic
and parasympathetic components of the ANS in patients with
PCOS. When compared with the control group, SSR latencies ob-
tained from the right hand were delayed in the patient group and a
decrease in SSR amplitude was observed. This result is compatible
with sympathetic dysfunction. The RRIV values obtained during a
deep breath were observed to be much lower for the patient group
than the control group, indicating a parasympathetic dysfunction.
Researchers have used several different methods to assess the
ANS. Cardiovascular tests, biochemical tests, and electrophysio-
logical tests are the most commonly used tests. These tests may
have some advantages and disadvantages compared with each
other. Therefore, assessment using different methods will increase
accuracy.
Excessive sympathetic innervation may play a role in polycystic
ovaries. In a study, it was found that rats with estrogen-induced
polycystic ovaries had a high uptake and level of norepinephrine,
and a high degree of transmitter release after electrical stimulation
of the ovary. [18]. As women with PCOS have signiﬁcantly higher
sympathetic nerve activity, this may be associated with hormonal
andmetabolic features that may be relevant to the pathophysiology
of the syndrome [19]. Garcia-Rudaz et al [20] showed that there is
an alteration in noradrenaline deamination and/or uptake in ado-
lescents with PCOS. Heart rate recovery (HRR) after exercise is a
marker of parasympathetic activity and attenuation of this
parameter has been shown to be associated with increased long-
term mortality [21e24]. A delayed recovery of systolic blood
pressure after peak exercise has been found to have diagnostic
value and might reﬂect sympathetic hyperactivity [25,26]. In
addition, the analysis of variations in heart rate (HRV) has also been
used to determine the balance between sympathetic and vagal
nerve activities in the heart [27]. HRV in PCOS was evaluated in
previous studies [9,28,29]. Yildirir et al [9] indicated a signiﬁcant
increase in the low frequency component of the HRV spectrum and
a decrease in the high frequency component in relation to the
control group. Tekin et al [29] showed a decrease in heart rate re-
covery and decreased 24-hour HRV measurement in patients with
PCOS [28]. Tekin et al [29] founded that the systolic blood pressure
of patients with PCOS remained signiﬁcantly elevated whenTable 3
The correlations between ReR interval variation, age, and body mass index.
Age p BMI p
rp rp
RRIV Rest 0.48 0.47 0.14 0.22
RRIV Breathing 0.04 0.70 0.19 0.11
BMI ¼ body mass index; RRIV ¼ ReR interval variation.compared with controls at the ﬁrst, second, and third minute of
recovery.
Sverrisdottir et al [19] indicated that there is sympathetic nerve
activity in womenwith PCOS. Tekin et al [29] showed that patients
with PCOS have attenuated HRR1. Kaya et al [30] founded that HRV
was signiﬁcantly decreased in women with PCOS. Post exercise,
slow HRR has been demonstrated as a risk factor for cardiovascular
and all-cause mortality in healthy adults [31]. Mean RRIV during
deep breathing was signiﬁcantly delayed in the present study.
These ﬁndings indicate parasympathetic dysfunction.
Previous studies have suggested that there is an autonomic
dysfunction in patients with PCOS. Insulin resistance, hyper-
androgenism, and obesity in patients with PCOS may be respon-
sible for autonomic dysfunction [9,29,31,32]. The insulin resistance
of women with PCOS had been reported to be the link between
PCOS and cardiovascular autonomic dysfunction [33]. In this study,
we reported no association between BMI, RRIV, and age; and be-
tween BMI, SSR, and age. However, we reported that patients with
PCOS had signiﬁcantly higher levels of testosterone and insulin
than that of controls. Therefore, we considered the potential role of
hyperandrogenism and insulin resistance in ANS dysfunction of
women with PCOS. A previous study reported that androgen levels
might regulate blood pressure levels in women with PCOS [34].
Autonomic dysfunction has been regarded as a predictor of car-
diovascular events and mortality [35,36]. Therefore, early and easy
diagnosis of autonomic dysfunction is very important.
This study has some limitations. Firstly, our study group was
relatively small. Thus, further larger studies are required to conﬁrm
these results. Secondly, there were not any other cardiac tests used
in this study.
In conclusion, SSR and RRIV tests using EMG can be easily and
rapidly performed, and they may allow for separate testing of
parasympathetic functions and sympathetic functions. Accordingly,
both tests are very sensitive methods in assessing ANS function in
patients with PCOS. The results of the present study indicate that
there are both parasympathetic dysfunction and sympathetic
dysfunction in patients with PCOS.Conﬂicts of interest
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